Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-05-06 @ 4:10 AM
Study NCT ID:
NCT07374718
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-29
First Post:
2026-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
Sponsor:
Shenyang Northern Hospital
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Dual Antiplatelet Therapy (DAPT) | View |
| None | Acute Coronary Syndrome (ACS) | View |
| None | High Bleeding Risk (HBR) | View |
| None | Percutaneous Coronary Intervention (PCI) | View |
| None | Quality Control Indicators | View |
| None | Coronary Revascularization | View |
| None | Real-World Research | View |
| None | Bleeding Events | View |
| None | Ischemic Events | View |
| None | Post-PCI Prognosis | View |